These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 4184596
21. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders. Lichtman MA. Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283 [No Abstract] [Full Text] [Related]
22. [Myelofibrosis during hematologic diseases. Apropos of 402 cases]. Devred C, Diebold J. Sem Hop; 1974 May 20; 50(24):1625-34. PubMed ID: 4373832 [No Abstract] [Full Text] [Related]
23. [Unusual case of chronic myeloproliferative syndrome]. Tosato F, Fossaluzza V. Arch Sci Med (Torino); 1982 May 20; 139(4):531-5. PubMed ID: 6891999 [Abstract] [Full Text] [Related]
24. Diagnostic evaluation of the chronic myeloproliferative disorders. Spivak JL. Isr Med Assoc J; 2002 Nov 20; 4(11):1028-31. PubMed ID: 12489498 [No Abstract] [Full Text] [Related]
25. Cytogenetic studies in the chronic myeloproliferative syndrome. Kiossoglou KA, Mitus WJ, Dameshek W. Blood; 1966 Aug 20; 28(2):241-52. PubMed ID: 5222584 [No Abstract] [Full Text] [Related]
26. Comments on feline leukemia: clinical and pathologic features, differential diagnosis. Schalm OW. J Am Vet Med Assoc; 1971 Mar 15; 158(6):Suppl 2:1025+. PubMed ID: 5280564 [No Abstract] [Full Text] [Related]
27. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading. Thiele J, Kvasnicka HM. Pathobiology; 2007 Mar 15; 74(2):89-96. PubMed ID: 17587880 [Abstract] [Full Text] [Related]
28. Myeloproliferative disorder and tuberculosis. Herman I. Calif Med; 1966 Oct 15; 105(4):287-90. PubMed ID: 5976885 [No Abstract] [Full Text] [Related]
29. Diagnostic and prognostic values of measurement of serum vitamin B12-binding proteins. Herbert V. Blood; 1968 Aug 15; 32(2):305-12. PubMed ID: 4175078 [No Abstract] [Full Text] [Related]
30. Diagnostic experiences with the naphthol AS-D chloroacetate esterase reaction. Leder LD. Blut; 1970 Jul 15; 21(1):1-8. PubMed ID: 4988077 [No Abstract] [Full Text] [Related]
31. [The significance of muramidase (lysozyme) determinations in hematologic diseases]. Mets T, Carlier A, Van Hove W. Ned Tijdschr Geneeskd; 1976 Nov 20; 120(47):2039-44. PubMed ID: 1070575 [No Abstract] [Full Text] [Related]
32. The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders. Rachmilewitz B, Rachmilewitz M. Isr J Med Sci; 1977 Jul 20; 13(7):710-5. PubMed ID: 270474 [No Abstract] [Full Text] [Related]
33. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification. Kvasnicka HM, Thiele J. Pathobiology; 2007 Jul 20; 74(2):63-71. PubMed ID: 17587877 [Abstract] [Full Text] [Related]
35. [T1 value of hyperplastic and hypoplastic bone marrow--preliminary report]. Asai S, Yoshida H, Yoshikawa H, Yashiro N, Lio M, Takaku F. Rinsho Hoshasen; 1985 Mar 20; 30(3):351-3. PubMed ID: 3860675 [No Abstract] [Full Text] [Related]